LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | WZ3105 | 0.37 | uM | LJP5 | 1 | D22 | 72 | hr | 868 | 671 | 3486 | 0.1925 | -0.0753 |
MDA-MB-231 | WZ3105 | 0.37 | uM | LJP5 | 2 | D22 | 72 | hr | 868 | 789 | 3486 | 0.2263 | -0.0302 |
MDA-MB-231 | WZ3105 | 0.37 | uM | LJP5 | 3 | D22 | 72 | hr | 868 | 745 | 3486 | 0.2137 | -0.0470 |
MDA-MB-231 | XMD11-50 | 0.37 | uM | LJP6 | 1 | P10 | 72 | hr | 868 | 1803 | 3486 | 0.5172 | 0.3571 |
MDA-MB-231 | XMD11-50 | 0.37 | uM | LJP6 | 2 | P10 | 72 | hr | 868 | 2027 | 3486 | 0.5814 | 0.4426 |
MDA-MB-231 | XMD11-50 | 0.37 | uM | LJP6 | 3 | P10 | 72 | hr | 868 | 1967 | 3486 | 0.5642 | 0.4197 |
MDA-MB-231 | Y39983 | 0.37 | uM | LJP6 | 1 | P04 | 72 | hr | 868 | 2402 | 3486 | 0.6890 | 0.5858 |
MDA-MB-231 | Y39983 | 0.37 | uM | LJP6 | 2 | P04 | 72 | hr | 868 | 3045 | 3486 | 0.8734 | 0.8314 |
MDA-MB-231 | Y39983 | 0.37 | uM | LJP6 | 3 | P04 | 72 | hr | 868 | 3098 | 3486 | 0.8886 | 0.8517 |
MDA-MB-231 | YM 201636 | 0.37 | uM | LJP5 | 1 | N10 | 72 | hr | 868 | 2924 | 3486 | 0.8387 | 0.7852 |
MDA-MB-231 | YM 201636 | 0.37 | uM | LJP5 | 2 | N10 | 72 | hr | 868 | 3466 | 3486 | 0.9942 | 0.9922 |
MDA-MB-231 | YM 201636 | 0.37 | uM | LJP5 | 3 | N10 | 72 | hr | 868 | 3038 | 3486 | 0.8714 | 0.8287 |
MDA-MB-231 | ZSTK474 | 0.37 | uM | LJP6 | 1 | M16 | 72 | hr | 868 | 2710 | 3486 | 0.7773 | 0.7035 |
MDA-MB-231 | ZSTK474 | 0.37 | uM | LJP6 | 2 | M16 | 72 | hr | 868 | 2753 | 3486 | 0.7896 | 0.7199 |
MDA-MB-231 | ZSTK474 | 0.37 | uM | LJP6 | 3 | M16 | 72 | hr | 868 | 2724 | 3486 | 0.7813 | 0.7088 |
MDA-MB-231 | Afatinib | 1.11 | uM | LJP6 | 1 | G21 | 72 | hr | 868 | 2455 | 3486 | 0.7042 | 0.6061 |
MDA-MB-231 | Afatinib | 1.11 | uM | LJP6 | 2 | G21 | 72 | hr | 868 | 2627 | 3486 | 0.7535 | 0.6718 |
MDA-MB-231 | Afatinib | 1.11 | uM | LJP6 | 3 | G21 | 72 | hr | 868 | 2797 | 3486 | 0.8023 | 0.7367 |
MDA-MB-231 | Sigma A6730 | 1.11 | uM | LJP5 | 1 | B21 | 72 | hr | 868 | 2485 | 3486 | 0.7128 | 0.6175 |
MDA-MB-231 | Sigma A6730 | 1.11 | uM | LJP5 | 2 | B21 | 72 | hr | 868 | 2650 | 3486 | 0.7601 | 0.6806 |
MDA-MB-231 | Sigma A6730 | 1.11 | uM | LJP5 | 3 | B21 | 72 | hr | 868 | 2700 | 3486 | 0.7744 | 0.6997 |
MDA-MB-231 | Alvocidib | 1.11 | uM | LJP6 | 1 | A15 | 72 | hr | 868 | 700 | 3486 | 0.2008 | -0.0642 |
MDA-MB-231 | Alvocidib | 1.11 | uM | LJP6 | 2 | A15 | 72 | hr | 868 | 661 | 3486 | 0.1896 | -0.0791 |
MDA-MB-231 | Alvocidib | 1.11 | uM | LJP6 | 3 | A15 | 72 | hr | 868 | 616 | 3486 | 0.1767 | -0.0963 |
MDA-MB-231 | AT-7519 | 1.11 | uM | LJP6 | 1 | K03 | 72 | hr | 868 | 590 | 3486 | 0.1692 | -0.1062 |